VASH2 is a promoter of an angiogenesis pathway it is therefore expected to promote cancer and indeed higher expression of VASH2 is associated with poor progression of pancreatic cancer36, esophageal squamous cell carcinoma37, breast cancer38 and epithelial-mesenchymal transition (EMT) in HCC39. This evidence concerns the gene VASH2 and cancer.